ClassID:

21647

A61K2300/00 - page 20 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#5701
20120177590
2012-07-12

Soft anticholinergic esters

#5702
20120177586
2012-07-12

Melanin modification compositions and methods of use

#5703
20120177574
2012-07-12

MICROVESICLES DERIVED FROM NUCLEATED, MAMMALIAN CELLS AND USE THEREOF

#5704
20120174260
2012-07-05

Nucleic acid molecules that target the RHO1 small GTP-binding protein and confer resistance to coleopteran pests

#5705
20120174259
2012-07-05

Nucleic acid molecules that target the vacuolar atpase C subunit and confer resistance to coleopteran pests

#5706
20120172836
2012-07-05

Implantable device for production of interleukin-1 receptor antagonist

#5707
20120172450
2012-07-05

USE OF JASMONATE FOR IMPROVING SKELETAL MUSCLE FUNCTION

#5708
20120172446
2012-07-05

L-serine to be used as a drug for preventing and/or treating an inflammatory response of the skin

#5709
20120172435
2012-07-05

Methods for treating acute acoustic trauma

#5710
20120172432
2012-07-05

PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND A CARDIOVASCULAR AGENT AND METHODS OF USING THE SAME

#5711
20120172431
2012-07-05

OMEGA 3 FATTY ACID FORMULATIONS

#5712
20120172429
2012-07-05

PERMANENTLY CHARGED SODIUM AND CALCIUM CHANNEL BLOCKERS AS ANTI- INFLAMMATORY AGENTS

#5713
20120172425
2012-07-05

RED YEAST RICE EXTRACT HIGH IN MONACOLIN K CONTENT

#5714
20120172420
2012-07-05

Method for modulating responsiveness to steroids

#5715
20120172398
2012-07-05

Co-crystals of tramadol and coxibs

#5716
20120172390
2012-07-05

METHOD OF TREATING SLEEP DISORDERS USING THE COMBINATION OF EPLIVANSERIN AND ZOLPIDEM

#5717
20120172388
2012-07-05

Enhancement of Impaired Motor and Mental Functions, Using Dextromethorphan and Oxidase Enzyme Inhibitor

#5718
20120172387
2012-07-05

OPIOIDS FOR THE TREATMENT OF THE RESTLESS LEG SYNDROME

#5719
20120172373
2012-07-05

Method of treating cognitive impairments and schizophrenias

#5720
20120172371
2012-07-05

Fluoroquinolone derivatives or sulfonamide moiety-containing compounds as inhibitors of tyrosyl-dnaphosphodiesterase (TDP1)

#5721
20120172346
2012-07-05

Use of nicotinic acetylcholine receptor alpha 7 activators

#5722
20120172343
2012-07-05

Pharmaceutical composition for emergency contraception

#5723
20120172341
2012-07-05

Compositions comprising tramadol and celecoxib in the treatment of pain

#5724
20120172331
2012-07-05

Methods of using human milk oligosaccharides for improving airway respiratory health

#5725
20120172329
2012-07-05

PHYTOCHEMICAL COMPOSITIONS INCLUDING XANTHONES FOR ANTI-INFLAMMATORY, ANTI-CYTOKINE STORM, AND OTHER USES

#5726
20120172327
2012-07-05

Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof

#5727
20120172325
2012-07-05

Methods and Compositions for the Treatment of Gastrointestinal Disorders

#5728
20120172324
2012-07-05

Compositions and methods for reducing the risk of agent-induced liver toxicity

#5729
20120172319
2012-07-05

Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides

#5730
20120172304
2012-07-05

Intranasal carbetocin formulations and methods for the treatment of autism

#5731
20120172301
2012-07-05

Pharmaceutical compositions comprising angiotensin-(1-9), derivatives thereof, or a vector expressing ACE2, useful for treating cardiovascular, pulmonary, cerebral, and/or renal remodeling

#5732
20120172298
2012-07-05

GLP-1 AND FGF21 COMBINATIONS FOR TREATMENT OF DIABETES TYPE 2

#5733
20120172292
2012-07-05

METHOD FOR PROTECTION OF ANTIMICROBIAL AND ANTICANCER DRUGS FROM INACTIVATION BY NITRIC OXIDE

#5734
20120172285
2012-07-05

Methods and compositions for specific modulation of MCL-1

#5735
20120171311
2012-07-05

SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING EPA OR DERIVATIVES THEREOF, OPTIONALLY, DHA OR DERIVATIVES THEREOF AND MONACOLIN K

#5736
20120171307
2012-07-05

Magnesium compositions and uses thereof for neurological disorders

#5737
20120171303
2012-07-05

COMPOSITIONS AND METHODS FOR EHNANCING COGNITIVE AND RELATED FUNCTIONS IN ANIMALS

#5738
20120171302
2012-07-05

Compositions for inhibiting redox-sensitive GTPases

#5739
20120171300
2012-07-05

Durable Antimicrobial Composition Including a Surfactant

#5740
20120171298
2012-07-05

USE OF PHARMACEUTICAL COMPOSITIONS IN PREPARING PHARMACEUTICALS FOR TREATING DIABETIC ULCER

#5741
20120171288
2012-07-05

Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application

#5742
20120171285
2012-07-05

SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS COMPRISING OMEGA-3 POLYUNSATURATED FATTY ACID OR DERIVATIVES THEREOF AND HIGH-MONACOLIN K CONTENT RED YEAST RICE EXTRACT

#5743
20120171276
2012-07-05

Virus inactivating sheet

#5744
20120171275
2012-07-05

Local administration of gallium compositions to treat pain

#5745
20120171273
2012-07-05

Oral compositions for skin benefits

#5746
20120171253
2012-07-05

Fibromodulin peptide

#5747
20120171240
2012-07-05

Immunostimulatory compositions and methods

#5748
20120171228
2012-07-05

Synergistic combination of honokiol and modified citrus pectin in cancer therapy

#5749
20120171206
2012-07-05

Methods of stimulating liver regeneration

#5750
20120171203
2012-07-05

Activin receptor-like kinase-1 compositions and methods of use

#5751
20120171201
2012-07-05

METHODS OF TREATING HER2 POSITIVE CANCER WITH HER2 RECEPTOR ANTAGONIST IN COMBINATION WITH MULTI-ARM POLYMERIC CONJUGATES OF 7-ETHYL-10-HYDROXYCAMPTOTHECIN

#5752
20120171187
2012-07-05

Debriding composition from bromelain and methods of production thereof

#5753
20120171182
2012-07-05

METHODS AND COMPOSITIONS FOR THE TREATMENT, PREVENTION, AND ALLEVIATION OF BONE AND CARTILAGE DISEASES OR INJURIES AND HAIR LOSS

#5754
20120171181
2012-07-05

COMPOSITIONS AND MINIMALLY INVASIVE METHODS FOR TREATING CANCER

#5755
20120171180
2012-07-05

COMPOSITIONS COMPRISING AMNION DERIVED ADHERENT CELLS AND PLATELET-RICH PLASMA

#5756
20120171179
2012-07-05

APPARATUS, SYSTEM, AND METHOD FOR COMPOSITIONS AND METHODS FOR TREATING, PREVENTING, OR ALLEVIATING BONE OR CARTILAGE DISEASES

#5757
20120171176
2012-07-05

Use of nutritional compositions including lactoferrin and one or more prebiotics in inhibiting adhesion of pathogens in the gastrointestinal tract

#5758
20120171171
2012-07-05

Methods and compositions for in vitro and in vivo chondrogenesis

#5759
20120171166
2012-07-05

SYNBIOTIC COMBINATION OF PROBIOTIC AND HUMAN MILK OLIGOSACCHARIDES TO PROMOTE GROWTH OF BENEFICIAL MICROBIOTA

#5760
20120171164
2012-07-05

USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN SUPPORTING RESISTANCE TO VIRAL RESPIRATORY TRACT INFECTIONS

#5761
20120171163
2012-07-05

METHOD FOR INHIBITING A BACTERIAL INVASIVE MECHANISM USING A NUTRITIONAL COMPOSITION

#5762
20120171161
2012-07-05

COMPOSITIONS COMPRISING PLACENTAL STEM CELLS AND PLATELET RICH PLASMA, AND METHODS OF USE THEREOF

#5763
20120171153
2012-07-05

Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions

#5764
20120171150
2012-07-05

Ion Bonding Pharmaceutical Composition

#5765
20120171130
2012-07-05

Mitigation of Animal and Plant Diseases Using Bioavailable Minerals

#5766
20120165795
2012-06-28

Therapeutic agent reservoir delivery system

#5767
20120165787
2012-06-28

Compositions and methods for treating joints

#5768
20120165731
2012-06-28

Compositions and methods for treating joints

#5769
20120165404
2012-06-28

TREATMENT OF NEURODEGENERATION AND NEUROINFLAMMATION

#5770
20120165363
2012-06-28

Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders

#5771
20120165361
2012-06-28

DRUG COATING PROVIDING HIGH DRUG LOADING AND METHODS FOR PROVIDING THE SAME

#5772
20120165359
2012-06-28

Opioid agonist/antagonist combinations

#5773
20120165358
2012-06-28

CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS

#5774
20120165355
2012-06-28

METHODS AND COMPOSITIONS FOR TREATING CANCERS

#5775
20120165347
2012-06-28

Compounds and their use as BACE inhibitors

#5776
20120165302
2012-06-28

ANTIFUNGAL FORMULATIONS

#5777
20120165301
2012-06-28

BENZODIAZEPINE COMPOSITIONS FOR TREATING EPIDERMAL HYPERPLASIA AND RELATED DISORDERS

#5778
20120165299
2012-06-28

COMBINATION MEDICAMENT

#5779
20120165287
2012-06-28

COMBINED TREATMENT OF CANCER BY UROKINASE INHIBITION AND A CYTOSTATIC ANTI-CANCER AGENT FOR ENHANCING THE ANTI-METASTATIC EFFECT

#5780
20120165286
2012-06-28

Cyclic nucleotide analogs

#5781
20120165285
2012-06-28

COMBINED PREPARATION FOR USE AS A MEDICAMENT

#5782
20120165273
2012-06-28

Eye drops

#5783
20120165259
2012-06-28

Agent for ameliorating blood-brain barrier disorders

#5784
20120165258
2012-06-28

Compositions and methods for treatment of thrombosis and for prolonging survival of stored platelets

#5785
20120165257
2012-06-28

Compositions and methods for treating joints

#5786
20120165254
2012-06-28

Sulphated hyaluronic acid for treating degenerative osteoarthritis

#5787
20120165252
2012-06-28

Method of regulating glucose metabolism, and reagents related thereto

#5788
20120165251
2012-06-28

Diabetes therapy

#5789
20120165243
2012-06-28

Use of dietary fibres against muscle wasting

#5790
20120164604
2012-06-28

UNEXTRACTED TOOTH ROOT CANAL FILLER AND DENTAL TISSUE REGENERATION METHOD FOR UNEXTRACTED TOOTH

#5791
20120164264
2012-06-28

Herbal composition for weight management

#5792
20120164249
2012-06-28

Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, and preparation method and use thereof

#5793
20120164247
2012-06-28

Medicinal and herbal composition and uses thereof

#5794
20120164245
2012-06-28

Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same

#5795
20120164244
2012-06-28

Combination of proanthocyanidins and centella asiatica for the treatment of atherosclerosis

#5796
20120164240
2012-06-28

ENRICHED A. BLITOIDES COMPOSITIONS AND USES THEREOF

#5797
20120164235
2012-06-28

Hydrogel formulation comprising oxidative reductive potential water

#5798
20120164228
2012-06-28

Pharmaceutical formulations to prevent the misuse of medicinal drugs

#5799
20120164227
2012-06-28

Granulating process and thus prepared granulate

#5800
20120164224
2012-06-28

Hemostatic preparation containing an extract of golden moss

#5801
20120164221
2012-06-28

COMBINATIONS OF HMG-COA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT

#5802
20120164219
2012-06-28

Peroral tablet for bowel cleansing

#5803
20120164218
2012-06-28

Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same

#5804
20120164215
2012-06-28

Topical co-enzyme Q10 formulations and methods of use

#5805
20120164213
2012-06-28

Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application

#5806
20120164211
2012-06-28

COMPOSITIONS AND METHODS FOR TREATING LYMPHOMA

#5807
20120164193
2012-06-28

Extended-release formulation for reducing the frequency of urination and method of use thereof

#5808
20120164192
2012-06-28

Delayed release formulation for reducing the frequency of urination and method of use thereof

#5809
20120164187
2012-06-28

BIOACTIVE GLASS FOR USE IN CONDITIONS RELATING TO BONE INFECTIONS

#5810
20120164180
2012-06-28

Method of identifying tumor associated antigens

#5811
20120164172
2012-06-28

Cancer therapy

#5812
20120164148
2012-06-28

Compositions Containing JARID1B Inhibitors and Methods for Treating Cancer

#5813
20120164124
2012-06-28

Phage-associated lytic enzymes for treatment of and related conditions

#5814
20120164120
2012-06-28

NOVEL MONASCUSPURPURONES, PREPARATION PROCESS THEREOF, AND USES OF THE MONASCUSPURPURONES

#5815
20120164115
2012-06-28

Methods related to surgery

#5816
20120164071
2012-06-28

Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives

#5817
20120157976
2012-06-21

Methods for treating neurological conditions and compositions and materials therefor

#5818
20120157751
2012-06-21

INTRACORONARY DEVICE AND METHOD OF USE THEREOF

#5819
20120157667
2012-06-21

Methods Of Producing Humanized Non-Human Mammals

#5820
20120157547
2012-06-21

COMPOSITIONS AND APPLICATIONS OF CAROTENOIDS OF IMPROVED ABSORPTION AND BIOAVAILABILITY

#5821
20120157534
2012-06-21

COMPOSITIONS AND METHODS OF TREATMENT FOR INFLAMMATORY DISEASES

#5822
20120157533
2012-06-21

Magnesium compositions and uses thereof for metabolic disorders

#5823
20120157532
2012-06-21

Method Of Treating Or Preventing A Convulsive Disorder In A Patient In Need Thereof

#5824
20120157531
2012-06-21

COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES

#5825
20120157525
2012-06-21

Treating eczema and/or psoriasis

#5826
20120157520
2012-06-21

Dioxanes derived from regrouping carbohydrates and C-glycosides, process for obtaining same and uses thereof

#5827
20120157519
2012-06-21

TELLERIUM-CONTAINING COMPOUNDS FOR TREATING VIRAL INFECTIONS

#5828
20120157515
2012-06-21

Methods and compositions for the treatment of "Burning Feet Syndrome"

#5829
20120157508
2012-06-21

Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions

#5830
20120157500
2012-06-21

JAK INHIBITION BLOCKS RNA INTERFERENCE ASSOCIATED TOXICITIES

#5831
20120157477
2012-06-21

REVERSAL OF L-DOPA-INDUCED DYSKINESIA BY NEURONAL NICOTINIC RECEPTOR LIGANDS

#5832
20120157475
2012-06-21

Combination Preparation Against Vertigo

#5833
20120157472
2012-06-21

METHOD FOR TREATING COLORECTAL CANCER

#5834
20120157426
2012-06-21

Mutant-selective EGFR inhibitors and uses thereof

#5835
20120157415
2012-06-21

New Crystalline Form of Pemirolast

#5836
20120157410
2012-06-21

COMPOSITIONS AND TREATMENTS USING PYRIDAZINE COMPOUNDS AND CHOLINESTERASE INHIBITORS

#5837
20120157409
2012-06-21

Appetite suppressant product and method

#5838
20120157408
2012-06-21

Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer

#5839
20120157407
2012-06-21

Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

#5840
20120157405
2012-06-21

Methods and Compositions for the Treatment of "Burning Feet Syndrome"

#5841
20120157396
2012-06-21

PYRAZINAMIDE FOR IMMUNOSTIMULATION AND THE TREATMENT OF LEISHMANIASES

#5842
20120157377
2012-06-21

METHODS TO ENHANCE NIGHT VISION AND TREATMENT OF NIGHT BLINDNESS

#5843
20120156699
2012-06-21

Pathogenic TH17 Cells; related reagents and methods

#5844
20120156649
2012-06-21

Methods for treating dental diseases, disorders, and injuries

#5845
20120156316
2012-06-21

BIOCOMPATIBLE TEA TREE OIL COMPOSITIONS

#5846
20120156312
2012-06-21

Compositions for Inhibiting Growth of Cancer Stem Cells

#5847
20120156311
2012-06-21

COMBINATION THERAPY FOR CANCER COMPRISING A PLATINUM-BASED ANTINEOPLASTIC AGENT AND A BIOCOMPATIBLE ELECTRON DONOR

#5848
20120156310
2012-06-21

Method for prediction of therapeutic effect of chemotherapy employing expression level of dihydropyrimidine dehydrogenase gene as measure

#5849
20120156296
2012-06-21

ANTIOXIDANTS IN FISH OIL POWDER AND TABLETS

#5850
20120156292
2012-06-21

Stable compositions of famotidine and ibuprofen

#5851
20120156291
2012-06-21

Stable compositions of famotidine and ibuprofen

#5852
20120156287
2012-06-21

Use of vitelline protein B as a microencapsulating additive

#5853
20120156284
2012-06-21

ENHANCED BIOLOGICAL AUTOLOGOUS TISSUE ADHESIVE COMPOSITION AND METHODS OF PREPARATION AND USE

#5854
20120156280
2012-06-21

Myeloid derived suppressor cell inhibiting agents

#5855
20120156272
2012-06-21

Composition for cosmetic, pharmaceutical or dietary applications

#5856
20120156250
2012-06-21

Compositions and methods for cardiac therapy

#5857
20120156248
2012-06-21

Augmentation of titer for vaccination in animals

#5858
20120156247
2012-06-21

Biocomposition stimulant of the immune system, anti-tumor and anti-HIV

#5859
20120156244
2012-06-21

Nasal Compositions and Uses Thereof

#5860
20120156212
2012-06-21

Methods and compositions for treating neoplasia

#5861
20120156202
2012-06-21

AGE RELATED MACULAR DEGENERATION TREATMENT

#5862
20120156200
2012-06-21

METHOD OF TREATING CANCER

#5863
20120156199
2012-06-21

USE OF PICOPLATIN TO TREAT COLORECTAL CANCER

#5864
20120156190
2012-06-21

Influenza prevention and treatment composition

#5865
20120156188
2012-06-21

CHEMICAL METHOD FOR SEXUAL STERILIZATION AND LIBIDO ELIMINATION IN MALE MAMMALS

#5866
20120156185
2012-06-21

NUTRITIONAL COMPOSITIONS COMPRISING CITRUS FIBERS

#5867
20120156178
2012-06-21

Treatment of Peyronies disease

#5868
20120156171
2012-06-21

COSMETIC AND/OR DERMATOLOGICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF SENSITIVE OR DRY SKIN

#5869
20120156170
2012-06-21

DRUG COMPOSITION FOR ANGIOGENESIS THERAPY

#5870
20120156168
2012-06-21

Viruses for the treatment of cellular proliferative disorders

#5871
20120156163
2012-06-21

Methods of decreasing sebum production in the skin

#5872
20120156143
2012-06-21

Dosage forms of plant-derived cathartics

#5873
20120156131
2012-06-21

DIAGNOSIS AND TREATMENT OF TUMORS

#5874
20120150095
2012-06-14

Antimicrobial material and method for making the same

#5875
20120149777
2012-06-14

COMPOSITIONS AND METHODS FOR IMPROVING CELLULAR SURVIVAL AND REDUCING APOPTOSIS AFTER ISCHEMIC EPISODE IN THE BRAIN

#5876
20120149760
2012-06-14

Disabling autophagy as a treatment for lysosomal storage diseases

#5877
20120149730
2012-06-14

Methods and compositions using racemic, (R)-, and (S)-fexofenadine in combination with leukotriene inhibitors

#5878
20120149729
2012-06-14

Metalloenzyme inhibitor compounds

#5879
20120149724
2012-06-14

MODULATING ENDOGENOUS BETA-ENDORPHIN LEVELS

#5880
20120149722
2012-06-14

Heteroaryl compounds and uses thereof

#5881
20120149721
2012-06-14

Methylpyrrolopyrimidinecarboxamides

#5882
20120149716
2012-06-14

METHODS OF USING AND COMPOSITIONS COMPRISING PDE4 MODULATORS FOR TREATMENT, PREVENTION AND MANAGEMENT OF TUBERCULOSIS

#5883
20120149709
2012-06-14

Deuterated pyrazinoisoquinoline compounds

#5884
20120149695
2012-06-14

Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof

#5885
20120149690
2012-06-14

Compositions comprising azelastine and methods of use thereof

#5886
20120149672
2012-06-14

Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms

#5887
20120149667
2012-06-14

Pharmaceutical compositions for treating IBD

#5888
20120149666
2012-06-14

Compositions and methods of treatment for inflammatory diseases

#5889
20120149665
2012-06-14

Combination therapy for treating proliferative diseases

#5890
20120149664
2012-06-14

Transdermal composition of phosphatidylcholine and method for producing same

#5891
20120149659
2012-06-14

Compositions and methods for delivering an agent to a wound

#5892
20120149641
2012-06-14

Methods and compositions for regenerating articular cartilage

#5893
20120149639
2012-06-14

USE OF A DPP-IV INHIBITOR TO REDUCE HYPOGLYCEMIC EVENTS

#5894
20120149632
2012-06-14

Glycopeptide and lipoglycopeptide antibiotics with improved solubility

#5895
20120149062
2012-06-14

High purity lipopeptides

#5896
20120148695
2012-06-14

Pharmaceutical Compositions From Carapa Guianensis

#5897
20120148693
2012-06-14

Herbal drug composition for cartilage protection

#5898
20120148691
2012-06-14

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HYPERTENSION

#5899
20120148686
2012-06-14

Method of improving skin regeneration effect of medicinal materials by double boiling using earthenware pot

#5900
20120148685
2012-06-14

METHODS AND COMPOSITIONS FOR TREATING INSULIN RESISTANCE, DIABETES MELLITUS TYPE 2, METABOLIC SYNDROME AND RELATED DISORDERS

#5901
20120148684
2012-06-14

Methods useful in the treatment of bone resorption diseases

#5902
20120148683
2012-06-14

IMMUNE STIMULATING COMPOSITION COMPRISING AN EXTRACT OF ARONIA SP. IN COMBINATION WITH SELENIUM AND/OR ZINC

#5903
20120148676
2012-06-14

Artificial cell constructs for cellular manipulation

#5904
20120148668
2012-06-14

Intracoronary device and method of use thereof

#5905
20120148660
2012-06-14

Conjugates of synthetic TLR agonists and uses therefor

#5906
20120148655
2012-06-14

Multi-layered gradient vaginal ring

#5907
20120148649
2012-06-14

COMPOSITION FOR RESTORATION OF AGE RELATED TISSUE IN THE FACE OR SELECTED AREAS OF THE BODY

#5908
20120148627
2012-06-14

Compositions and methods for treatment of neoplastic disease

#5909
20120148621
2012-06-14

Methods and compositions for promoting a cell-mediated immune response

#5910
20120148612
2012-06-14

Grass peptides for vaccine

#5911
20120148611
2012-06-14

Cyclophosphamide in combination with anti-idiotypic vaccines

#5912
20120148609
2012-06-14

INTRACORONARY DEVICE AND METHOD OF USE THEREOF

#5913
20120148598
2012-06-14

Methods for treating a tumor using an antibody that specifically binds GRP94

#5914
20120148595
2012-06-14

GABA-LINKED ANTHRACYCLINE-LIPID CONJUGATES

#5915
20120148584
2012-06-14

VEGF-SPECIFIC ANTAGONISTS FOR ADJUVANT AND NEOADJUVANT THERAPY AND THE THREATMENT OF EARLY STAGE TUMORS

#5916
20120148567
2012-06-14

Particulate hyaluronic acid/flavonoid suspensions for cellular delivery of bioactive agents

#5917
20120148564
2012-06-14

METHODS OF USING SNS-595 FOR TREATMENT OF CANCER SUBJECTS WITH REDUCED BRCA2 ACTIVITY

#5918
20120148556
2012-06-14

Formulations for lysosomal enzymes

#5919
20120148554
2012-06-14

Therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes

#5920
20120148547
2012-06-14

COMBINATION OF VITAMIN E AND BETA-GLYCOSPHINGOLIPIDS IN COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING HEPATIC DISORDERS

#5921
20120148541
2012-06-14

COMPOSITIONS AND METHODS TO GENERATE PILOSEBACEOUS UNITS

#5922
20120148534
2012-06-14

Methods and compositions of treating a family viral infection

#5923
20120148533
2012-06-14

Combination therapy for proliferative disorders

#5924
20120148530
2012-06-14

Method for the treatment or prevention of virus infection using polybiguanide-based compounds

#5925
20120148495
2012-06-14

Methods for treating nicotinic acetylcholine receptor associated diseases

#5926
20120144510
2012-06-07

Treatment of astrocytes-tumor cells inhibitors of endothelin receptors

#5927
20120142941
2012-06-07

Composition for alleviating ultraviolet radiation-induced damage

#5928
20120142785
2012-06-07

METHODS FOR TREATING ALZHEIMER'S DISEASE

#5929
20120142784
2012-06-07

LYSINE-SPECIFIC DEMETHYLASE 1(LSD1) IS A BIOMARKER FOR BREAST CANCER

#5930
20120142777
2012-06-07

Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use

#5931
20120142770
2012-06-07

PHARMACEUTICAL COMPOSITIONS OF HDAC INHIBITORS AND CHELATABLE METAL COMPOUNDS, AND METAL-HDAC INHIBITOR CHELATE COMPLEXES

#5932
20120142769
2012-06-07

Methods for treating or preventing fatigue

#5933
20120142762
2012-06-07

Method for preventing and treating cardiovascular diseases with BRCA1

#5934
20120142755
2012-06-07

COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION

#5935
20120142735
2012-06-07

DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]- 1H-INDOL-3-YL]-METHANONES

#5936
20120142725
2012-06-07

Combined Use of an Alpha-Adrenergic Receptor Antagonist and an Anti-Muscarinic Agent

#5937
20120142719
2012-06-07

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof

#5938
20120142708
2012-06-07

Substituted pyridine urea compounds

#5939
20120142703
2012-06-07

NEW COMBINATION THERAPY IN TREATMENT OF ONCOLOGICAL AND FIBROTIC DISEASES

#5940
20120142692
2012-06-07

Antifolate combinations

#5941
20120142658
2012-06-07

THERAPEUTICAL USE OF TERNARY COMPLEXES OF VALPROIC ACID

#5942
20120142651
2012-06-07

METHOD OF TREATMENT OF ALLERGIC RHINITIS

#5943
20120142650
2012-06-07

METHOD FOR TREATING LUNG DISEASE

#5944
20120142649
2012-06-07

Compositions and methods for delivering clonidine and bupivacaine to a target tissue site

#5945
20120142648
2012-06-07

METHODS FOR DELIVERING CLONIDINE COMPOSITIONS IN BIODEGRADABLE POLYMER CARRIER AND LOCAL STERIODS TO A TARGET TISSUE SITE

#5946
20120142645
2012-06-07

NEUROACTIVE STEROID COMPOSITIONS AND METHODS OF USE FOR LOWERING CHOLESTEROL

#5947
20120142643
2012-06-07

Clonidine and GABA compounds in a biodegradable polymer carrier

#5948
20120142634
2012-06-07

Method of Treating Cancer with a Combination of a Proteasome Inhibitor and Salubrinal

#5949
20120142631
2012-06-07

MEDICINAL ANTIDIAPER RASH CREAM INCORPORATING A BIOPOLYMER AND A PROCESS TO MAKE IT

#5950
20120142627
2012-06-07

MONOPHOSPHATE PRODRUGS OF DAPD AND ANALOGS THEREOF

#5951
20120142605
2012-06-07

METHODS OF TREATING PSORIASIS

#5952
20120142601
2012-06-07

Modified Peptides and Uses Thereof

#5953
20120142598
2012-06-07

EDIBLE COMPOSITIONS FOR PREVENTING HAIR LOSS

#5954
20120142589
2012-06-07

TISSUE-PROTECTIVE CYTOKINES FOR THE PROTECTION, RESTORATION AND ENHANCEMENT OF RESPONSIVE CELLS, TISSUES AND ORGANS

#5955
20120142588
2012-06-07

HSP therapy in conjunction with a low antigenicity diet

#5956
20120142582
2012-06-07

Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders

#5957
20120141614
2012-06-07

Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin

#5958
20120141611
2012-06-07

METHODS AND COMPOSITIONS USING ERGOTHIONEINE TO TREAT A VARIETY OF HEALTH RELATED FACTORS

#5959
20120141610
2012-06-07

Novel Topical Composition Of Sarracenia Purpurea (Pitcher Plant)

#5960
20120141608
2012-06-07

SYSTEMIC ADMINISTRATION OF NAC AS AN ADJUNCT IN THE TREATMENT OF BIOTERROR EXPOSURES SUCH AS ANTHRAX, VIRUS OR RADIATION AND USE IN COMBINATION WITH DHEA FOR THE TREATMENT OF VIRUSES

#5961
20120141607
2012-06-07

Control of Enterohemorrhagic E. Coli in Farm Animal Drinking Water

#5962
20120141606
2012-06-07

SIGMA LIGANDS FOR THE PREVENTION OR TREATMENT OF PAIN INDUCED BY CHEMOTHERAPY

#5963
20120141594
2012-06-07

Composition with anti-inflammatory, protein synthesizing, treatment of enzyme deficiency, activating genetic therapy and anti-cancer activity and methods of use

#5964
20120141586
2012-06-07

THROMBIN RECEPTOR ANTAGONIST AND CLOPIDOGREL FIXED DOSE TABLET

#5965
20120141560
2012-06-07

Tumor and infectious disease therapeutic compositions

#5966
20120141555
2012-06-07

Composition and device for treating bone and/or cartilage defects

#5967
20120141554
2012-06-07

DELAYED RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF

#5968
20120141546
2012-06-07

OIL-BASED PREPARATION

#5969
20120141535
2012-06-07

Process and composition for treatment of canine and human leishmaniasis

#5970
20120141512
2012-06-07

Method of increasing immunological effect

#5971
20120141498
2012-06-07

USE OF PKC ISOZYMES FOR DIAGNOSIS AND TREATMENT OF NEUROBLASTOMA

#5972
20120141494
2012-06-07

Fully human antibodies against human 4-1BB

#5973
20120141479
2012-06-07

Histone Deacetylase Inhibitors Sensitize Cancer Cells To Epidermal Growth Factor Inhibitors

#5974
20120141475
2012-06-07

Concomitant treatment of rheumatoid arthritis with anti-TNF-α antibodies and methotrexate

#5975
20120141474
2012-06-07

Concomitant treatment of rheumatoid arthritis with anti-TNF-alpha antibodies and methotrexate

#5976
20120141468
2012-06-07

MAINTENANCE OF PLATELET INHIBITION DURING ANTIPLATELET THERAPY

#5977
20120141467
2012-06-07

Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma

#5978
20120141466
2012-06-07

Composition and method for treatment of reperfusion injury and tissue damage

#5979
20120141452
2012-06-07

Targeted therapeutic proteins

#5980
20120141448
2012-06-07

Method for increasing muscle mass and strength

#5981
20120141446
2012-06-07

Oral Nutritional Supplement Delivery System

#5982
20120141445
2012-06-07

NUTRITION FOR IMPROVING MUSCLE STRENGTH IN ELDERLY

#5983
20120141414
2012-06-07

Bimacrocylic HCV NS3 protease inhibitors

#5984
20120141413
2012-06-07

Use of IL-15 preparations to treat lymphopenia

#5985
20120141412
2012-06-07

Methods of treating idiopathic thrombocytopenic purpura with compositions comprising extracts of

#5986
20120141411
2012-06-07

Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response

#5987
20120141401
2012-06-07

Soft anticholinergic zwitterions

#5988
20120138506
2012-06-07

Methods of treatment and pharmaceutical composition

#5989
20120136338
2012-05-31

IMMUNOLOGIC COMPOUNDS FOR PREVENTION, PROTECTION, PROPHYLAXIS OR TREATMENT OF IMMUNOLOGICAL DISORDERS, INFECTIONS AND CANCER

#5990
20120136296
2012-05-31

Methods to regulate polarization and enhance function of excitable cells

#5991
20120136220
2012-05-31

Compositions and methods for enhancing brain function

#5992
20120136061
2012-05-31

Lycopene and resveratrol compositions for NK cell activation resulting in anti-neoplastic effect

#5993
20120136059
2012-05-31

Combinations of adapalene and benzoyl peroxide for treating acne lesions

#5994
20120136057
2012-05-31

HYDROXY FATTY ACID COMPOUNDS AND USES THEREOF FOR DISEASE TREATMENT AND DIAGNOSIS

#5995
20120136053
2012-05-31

COPEPOD OIL COMPOSITION, FORMULATIONS COMPRISING THE OIL COMPOSITION, AND THE USE THEREOF TO REDUCE ACCUMULATION OF VISCERAL FAT, IMPROVE GLUCOSE TOLERANCE, AND PREVENT OR TREAT OBESITY RELATED DISEASES AND DISORDERS

#5996
20120136048
2012-05-31

TOPICAL, PERIOCULAR, OR INTRAOCULAR USE OF TOCOTRIENOLS FOR THE TREATMENT OF OPHTHALMIC DISEASES

#5997
20120136030
2012-05-31

Combinations of MEK inhibitors and Raf kinase inhibitors and uses thereof

#5998
20120136029
2012-05-31

Compounds, pharmaceutical compositions and methods of use of 2-aryl pyridylazoles

#5999
20120136022
2012-05-31

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

#6000
20120136017
2012-05-31

Use of 4′-thio-2′-deoxynucleosides as anti orthopoxvirus agents